| Kristina N Fontaine, | |
|
54 Plain St, Lowell, MA 01851-4419 | |
| (978) 453-7538 | |
| Not Available |
| Full Name | Kristina N Fontaine |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 54 Plain St, Lowell, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174399018 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PHCY-01595 (New Hampshire) | Secondary |
| 183500000X | Pharmacist | PH997039 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristina N Fontaine, 5 Blueberry Ln, Hudson, NH 03051-5304 Ph: () - | Kristina N Fontaine, 54 Plain St, Lowell, MA 01851-4419 Ph: (978) 453-7538 |
News Archive
A new study shows that colonoscopy actually prevents cancer deaths. Although many people have assumed that colonoscopy must save lives because it is so often recommended, strong evidence has been lacking until now.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
Researchers at the Moffitt Cancer Center in Tampa, Fla., and colleagues have found that tumor cell resistance to a specific cancer immunotherapy designed to kill cancer cells can be blamed on a mechanism that involves the production of a free radical peroxynitrite (PNT) that causes resistance to therapeutic cancer-killing cells.
dbMotion, a provider of health interoperability solutions, announced its participation at HIMSS 2010, March 1-4 in Atlanta, Ga., both as an exhibitor (Booth 6023) and as a featured contributor to the Interoperability Showcase—demonstrating how providers can achieve meaningful data-sharing across a range of healthcare settings. Participation in the Interoperability Showcase comes on the heels of dbMotion's successful completion of interoperability testing at the 11th Annual IHE North American Connectathon in Chicago.
Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.
› Verified 7 days ago
Dr. Matthew Borden, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Lowell, MA 01852 Phone: 978-937-6000 | |
Holly A Hession, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 84 Surrey Ln, Lowell, MA 01852 Phone: 978-866-5482 | |
Michael John Jones, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 225 Stedman St Ste 27, Lowell, MA 01851 Phone: 978-458-4000 Fax: 978-459-2485 | |
Thu Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 54 Plain St, Lowell, MA 01851 Phone: 978-453-7538 | |
Greg A Deroma, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 130 Marshall Rd, Lowell, MA 01852 Phone: 978-671-9169 Fax: 978-671-9144 | |
Stergios Michael Dalkouras, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 54 Plain St, Lowell, MA 01851 Phone: 978-453-7538 | |
Minesh Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1161 Bridge St, Lowell, MA 01850 Phone: 251-605-4786 |